This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without ant...
Otitis Media/drug therapy,
Anti-Infective Agents/therapeutic use,
Drug Prescriptions/standards,
Drug Resistance, Microbial,
Cephalosporins/therapeutic use,
Acetaminophen/therapeutic use,
Ibuprofen/therapeutic use,
Analgesics, Non-Narcotic/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Tobacco Use Disorder/complications,
Placebos/therapeutic use,
Drug Resistance, Bacterial/drug effects,
Superinfection/prevention & control,
Amoxicillin/therapeutic use
A clinical summary of this KDP was published in the Journal of the Ministry of Health of the Czech Republic .
Nosocomial pneumonia (HAP - Hospital Acquired Pneumonia and VAP - Ventilator Associated Pneumonia) is the second most common nosocomial infection, and even the most common in patients in intens...
This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without ant...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve the ...
This document provides a summary of the evidence and recommendations for the use of SL-LPA for the detection of mutations associated with resistance to fluoroquinolones and SLID in patients with RR-TB and/or MDR-TB. The objectives of this policy guidance are to assess and compare the diagnostic accuracy ...
Tuberculosis, Multidrug-Resistant/diagnosis,
Antibiotics, Antitubercular/pharmacology,
Molecular Probe Techniques,
Microbial Sensitivity Tests,
Fluoroquinolones/therapeutic use,
Drug Resistance, Bacterial/genetics,
Genotype,
Mutation,
Tuberculosis, Multidrug-Resistant/genetics,
Mycobacterium tuberculosis/drug effects,
Mycobacterium tuberculosis/genetics
Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting cases earlier, including cases of smear-negative disease. This document updates existing WHO policy on the use of molecular LPAs for detecting MTBC a...
Molecular Probe Techniques,
Rifamycins/therapeutic use,
Isoniazid/therapeutic use,
Tuberculosis, Multidrug-Resistant/diagnosis,
Antitubercular Agents/therapeutic use,
Isoniazid/pharmacology,
Rifampin/pharmacology,
Mycobacterium tuberculosis/drug effects,
Drug Resistance, Bacterial,
Reproducibility of Results
Bretonnière, C;
Leone, M;
Milési, C;
Allaouchiche, B;
Armand-Lefevre, L;
Baldesi, O;
Bouadma, L;
Decré, D;
Figueiredo, S;
Gauzit, R;
Guery, B;
Joram, N;
Jung, B;
Lasocki, S;
Lepape, A;
Lesage, F;
Pajot, O;
Philippart, F;
Souweine, B;
Tattevin, P;
Timsit, J. F;
Vialet, R;
Zahar, J. R;
Misset, B;
Bedos, J. P.
Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Société de Réanimat...
